Joanne Schogger Selected Research

1- (1- methylethyl)- 4- ((1- (6- (trifluoromethyl)- 3- pyridinyl)- 4- piperidinyl)carbonyl)hexahydro- 1H- 1,4- diazepine

4/2007

Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanne Schogger Research Topics

Disease

3	Dementia (Dementias) 12/2013 - 04/2007
2	Alzheimer Disease (Alzheimer's Disease) 12/2013 - 06/2007
1	Cognitive Dysfunction 06/2007
1	Hyperalgesia 04/2007
1	Amnesia (Dissociative Amnesia) 04/2007
1	Neuralgia (Stump Neuralgia) 04/2007

Drug/Important Bio-Agent (IBA)

2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 12/2013 - 06/2007
2	6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA 12/2013 - 06/2007
1	GSK239512IBA 12/2013
1	Cholinergic Antagonists (Anticholinergics)IBA 04/2007
1	Histamine H3 AntagonistsIBA 04/2007
1	1- (1- methylethyl)- 4- ((1- (6- (trifluoromethyl)- 3- pyridinyl)- 4- piperidinyl)carbonyl)hexahydro- 1H- 1,4- diazepineIBA 04/2007
1	Capsaicin (Zostrix)FDA Link 04/2007
1	5- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 2- pyrazinecarboxamideIBA 04/2007
1	Scopolamine (Hyoscine)FDA Link 04/2007

Therapy/Procedure

1	Therapeutics 12/2013